NCT02355171暂停不适用
A Large-scale Longitudinal Oncology Registry
适应症
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 入组人数
- 10,000
- 试验地点
- 14
- 主要终点
- The primary objective of PMT is to create a collection of cancer patient biospecimens and annotated data that will be used for clinical trial matching and to advance cancer research.
研究概览
简要总结
The 'Personalize My treatment' (PMT) platform is a novel form of biobanking in which cancer patients willingly consent to provide residual, clinical samples (surplus after diagnostic testing) of their tumors for cancer research, to give access to their medical record for data collection and then followed prospectively throughout the trajectory of their illness. They further willingly consent to be recontacted for being informed of other research projects, including clinical trials.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
The primary objective of PMT is to create a collection of cancer patient biospecimens and annotated data that will be used for clinical trial matching and to advance cancer research.
时间窗: Longitudinal
次要结局
未报告次要终点
研究者
研究点 (14)
Loading locations...
相似试验
终止
不适用
Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon CancerMedullary Thyroid CancerColon CancerNCT02363647Icahn School of Medicine at Mount Sinai10
招募中
不适用
Registry Platform Gastric/Esophageal Cancer (SAPHIR)Esophageal Squamous Cell CarcinomaGastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaEsophageal AdenocarcinomaNCT04290806iOMEDICO AG1,900
进行中（未招募）
不适用
Registry Platform Colorectal CancerColorectal Cancer MetastaticNCT04867525iOMEDICO AG500
Unknown
不适用
Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.Metastatic CancerNCT02593578Samsung Medical Center2,000
已完成
不适用
Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.Colorectal CancerNCT02593591Samsung Medical Center40